학술논문
278 - Clinical Outcomes of Patients with Epstein–Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study
Document Type
Abstract
Author
Source
In Transplantation and Cellular Therapy March 2022 28(3) Supplement:S221-S222
Subject
Language
ISSN
2666-6367